Serum Levels of C-Reactive Protein and Interleukin-6 in Patients with Acute Streptococcal Tonsillitis
Kadar Protein C-Reaktif dan Interleukin-6 Serum pada Pasien dengan Tonsilitis Streptokokus Akut
Keywords:
Acute Streptococcal Tonsillitis, C-reactive protein, Interleukin-6, Inflammation, Biomarkers, Immune responseAbstract
Background; The tonsils get inflamed with acute streptococcal tonsillitis, which is a common bacterial illness mostly caused by Streptococcus pyogenes. Aims of the study: Look at the blood of people who have acute streptococcal tonsils and people who are healthy and not sick to see how much CRP and IL-6 are present. This will help you figure out what kind of illness it is and how bad it is. Methodology: The study looked at the amounts of C-reactive protein (CRP) and interleukin-6 (IL-6) in the blood of 100 people with acute streptococcal tonsils (as shown by positive throat swab cultures) and 50 healthy people of the same age and gender. It ran from January to April 2024. Blood samples were taken in a clean way, centrifuged to get serum, and then kept at -20°C. ELISA kits were used twice to measure the amounts of CRP and IL-6. We didn't include people who had long-term inflammatory diseases or who had recently taken antibiotics. Ethical approval was given for the study, and all subjects gave their informed permission. Result: The study found no significant differences between patients and controls in age, gender, smoking status, or BMI (p > 0.05). Patients showed significantly higher serum levels of CRP (18.6 ± 5.4 mg/L) and IL-6 (42.3 ± 9.8 pg/mL) compared to controls (CRP: 4.1 ± 1.2 mg/L; IL-6: 8.7 ± 2.6 pg/mL) with p < 0.001. A strong positive correlation existed between CRP and IL-6 (r = 0.742, p < 0.001). No significant gender differences were found for CRP or IL-6 levels (p > 0.05). Conclusions: The study concludes that elevated CRP and IL-6 levels in acute streptococcal tonsillitis reflect a strong inflammatory response driven by IL-6–mediated stimulation of CRP production. These biomarkers effectively indicate infection severity and immune activation.
Highlight :
-
The study demonstrates significantly elevated CRP and IL-6 levels in patients with acute streptococcal tonsillitis compared to healthy controls, indicating intense inflammation.
-
A strong positive correlation between CRP and IL-6 levels suggests interlinked immune pathways relevant for disease monitoring.
-
No significant gender differences were found in CRP and IL-6 levels, supporting the general applicability of these biomarkers.
Keywords : Acute streptococcal tonsillitis, C-reactive protein, Interleukin-6, Inflammation, Biomarkers, Immune response
References
[1] L. Norton dan A. Myers, "The Treatment of Streptococcal Tonsillitis/Pharyngitis in Young Children," World Journal of Otorhinolaryngology - Head and Neck Surgery, vol. 7, no. 3, pp. 161–165, Jul. 2021.
[2] D. B. Pylypiv, B. M. Sharga, O. A. Rishko, V. Leshak dan E. Karbovanets, "Relation of Streptococcus Pyogenes Tonsillitis Isolate to Antimicrobial Agents and Its Infection Treatment," unpublished.
[3] J. R. Lavillegrand et al., "Elevated Plasma IL-6 and CRP Levels Are Associated With Adverse Clinical Outcomes and Death in Critically Ill SARS-CoV-2 Patients," Annals of Intensive Care, vol. 11, pp. 1–10, Dec. 2021.
[4] A. A. Hamad, H. M. Mustafa dan O. A. Mohsein, "Detection of the Levels of Immune Cytokines (IL4, IL5, TNF-α) in School-Age and Preschoolers With an Ascaris Lumbricoides Infection," Journal of Parasitic Diseases, vol. 48, no. 4, pp. 782–787, 2024.
[5] F. Challa et al., "Serum Level of High Sensitive C-Reactive Protein and IL-6 Markers in Patients With Treatment-Resistant Schizophrenia in Ethiopia: A Comparative Study," BMC Psychiatry, vol. 21, no. 1, p. 428, Aug. 2021.
[6] S. Zhu et al., "The Clinical Diagnostic Values of SAA, PCT, CRP, and IL-6 in Children With Bacterial, Viral, or Co-Infections," International Journal of General Medicine, Oct. 2021.
[7] M. Largman-Chalamish et al., "Differentiating Between Bacterial and Viral Infections by Estimated CRP Velocity," PLoS One, vol. 17, no. 12, Dec. 2022.
[8] S. Mohammad, A. Mohsen dan I. Jalil, "Assessing the Prevalence of Bacterial Vaginosis Among Infertile Women in Thi-Qar Province, Iraq," Infection Epidemiology and Microbiology, vol. 10, no. 4, 2024.
[9] O. Unal, Y. C. Kumbul dan V. Akin, "Importance of Biomarkers in Streptococcal Acute Tonsillitis & Peritonsillar Abscess," The Indian Journal of Medical Research, vol. 159, no. 6, p. 637, Sep. 2024.
[10] M. De Paor, "Diagnosis and Management of Sore Throat in Young Adults," 2022.
[11] Y. Gan et al., "Causes of Lower Respiratory Tract Infections and the Use of Diagnostic Biomarkers in Blood Samples From Children in Hohhot, Inner Mongolia, China," Medical Science Monitor, vol. 28, 2022.
[12] Z. K. Abbas et al., "Immunological Biomarkers and Their Role in the Diagnosis and Prognosis of Leishmaniasis: A Case–Control Study," Tropical Parasitology, vol. 15, no. 1, pp. 33–41, 2025.
[13] A. A. Abdelalim et al., "Corticosteroid Nasal Spray for Recovery of Smell Sensation in COVID-19 Patients," American Journal of Otolaryngology, vol. 42, no. 2, p. 102884, Mar. 2021.
[14] J. Mariani et al., "High-Dose Vitamin D Versus Placebo to Prevent Complications in COVID-19 Patients," PLoS One, vol. 17, no. 5, May 2022.
[15] N. H. Naif et al., "The Impact of Inflammatory and Adipokine Biomarkers on Breast Cancer Progression and Patient Outcomes," Bulletin of Pharmaceutical Sciences Assiut University, vol. 48, no. 1, pp. 511–522, 2025.
[16] D. B. Shabeeb dan E. N. Naji, "Relationship Between Blood Components, Inflammatory Factors and Bacterial spp That Cause Tonsillitis and Dental Caries in Iraqi Children," Reviews and Research in Medical Microbiology, vol. 34, no. 3, pp. 149–152, Jul. 2023.
[17] M. M. Elbahrawy, M. M. Wafai dan A. S. Essa, "Evaluation of Antistreptolysin O Titer, Erythrocyte Sedimentation Rate and C Reactive Protein Before and After Tonsillectomy," Al-Azhar Assiut Medical Journal, vol. 23, no. 1, pp. 89–94, Jan. 2025.
[18] I. A. Abdel-Shafy et al., "Evaluation of Erythrocyte Sedimentation Rate, C Reactive Protein and Antistreptolysin O Titer Regarding Tonsillectomy Indication," Egyptian Journal of Ear, Nose, Throat and Allied Sciences, vol. 22, no. 22, pp. 1–5, Jan. 2021.
[19] A. M. A. Faqri et al., "The Role of Cytokines in Autoimmune Diseases: Pathogenesis and Therapeutic Implications," Central Asian Journal of Medical and Natural Sciences, vol. 6, no. 3, pp. 852–873, 2025.
[20] Q. Lu et al., "Changes of Serum IL‐10, IL‐1β, IL‐6, MCP‐1, TNF‐α, IP‐10 and IL‐4 in COVID‐19 Patients," International Journal of Clinical Practice, vol. 75, no. 9, Sep. 2021.
[21] A. D. Hussein et al., "Emerging Biomarkers in Cancer Detection and Prognosis: A Comprehensive Review," International Journal of Immunology, vol. 7, no. 1, pp. 1–12, 2025.
[22] A. S. Tripathy et al., "Pro-Inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: Biomarkers of SARS-CoV-2 Infection," Archives of Virology, vol. 166, pp. 3301–3310, Dec. 2021.
[23] E. A. Said et al., "Defining IL-6 Levels in Healthy Individuals: A Meta-Analysis," Journal of Medical Virology, vol. 93, no. 6, pp. 3915–3924, Jun. 2021.
[24] J. M. Galván-Román et al., "IL-6 Serum Levels Predict Severity and Response to Tocilizumab in COVID-19," Journal of Allergy and Clinical Immunology, vol. 147, no. 1, pp. 72–80, Jan. 2021.
[25] F. Kesmez Can et al., "Effect of IL-6, IL-8/CXCL8, IP-10/CXCL10 Levels on the Severity in COVID-19 Infection," International Journal of Clinical Practice, vol. 75, no. 12, Dec. 2021.
[26] F. Hidayat et al., "Correlation of Interleukin-6 and C-Reactive Protein Levels in Plasma With the Stage and Differentiation of Colorectal Cancer," Annals of Medicine and Surgery, vol. 62, pp. 334–340, Feb. 2021.
[27] O. M. Koper-Lenkiewicz et al., "The Relationship Between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage," Diagnostics, vol. 11, no. 8, p. 1382, Jul. 2021.
[28] W. Feng, L. Zhu, Y. Liu, L. Xu dan H. Shen, "C‐Reactive Protein/Albumin Ratio and IL‐6 Are Associated With Disease Activity in Patients With Ulcerative Colitis," Journal of Clinical Laboratory Analysis, vol. 37, no. 3, Feb. 2023.
[29] M. Solmi et al., "Peripheral Levels of C-Reactive Protein, Tumor Necrosis Factor-α, Interleukin-6, and Interleukin-1β Across the Mood Spectrum in Bipolar Disorder," Brain, Behavior, and Immunity, vol. 97, pp. 193–203, Oct. 2021.
[30] D. Adamis, W. A. van Gool dan P. Eikelenboom, "Consistent Patterns in the Inconsistent Associations of Insulin-Like Growth Factor 1 (IGF-1), C-Reactive Protein and Interleukin-6 With Delirium," Archives of Gerontology and Geriatrics, vol. 97, p. 104518, Nov. 2021.
[31] F. Manole et al., "Biomarker Analysis in Upper Respiratory Tract Infections: Associations With Demographics and Clinical Outcomes," Pediatric Reports, vol. 17, no. 1, Dec. 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Safaa A. AL-Isawi
This work is licensed under a Creative Commons Attribution 4.0 International License.
